000 | 01845 a2200469 4500 | ||
---|---|---|---|
005 | 20250515031810.0 | ||
264 | 0 | _c20060809 | |
008 | 200608s 0 0 eng d | ||
022 | _a0022-1767 | ||
024 | 7 |
_a10.4049/jimmunol.177.1.155 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMcWilliams, Jennifer A | |
245 | 0 | 0 |
_aA modified tyrosinase-related protein 2 epitope generates high-affinity tumor-specific T cells but does not mediate therapeutic efficacy in an intradermal tumor model. _h[electronic resource] |
260 |
_bJournal of immunology (Baltimore, Md. : 1950) _cJul 2006 |
||
300 |
_a155-61 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntigens, Neoplasm _xmetabolism |
650 | 0 | 4 |
_aCancer Vaccines _xadministration & dosage |
650 | 0 | 4 |
_aCell Adhesion _ximmunology |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aEpitopes, T-Lymphocyte _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aH-2 Antigens _xmetabolism |
650 | 0 | 4 | _aInjections, Intradermal |
650 | 0 | 4 |
_aIntramolecular Oxidoreductases _xadministration & dosage |
650 | 0 | 4 |
_aLymphocyte Activation _ximmunology |
650 | 0 | 4 |
_aMelanoma, Experimental _ximmunology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aNeoplasm Transplantation |
650 | 0 | 4 |
_aPeptides _xadministration & dosage |
650 | 0 | 4 |
_aProtein Binding _ximmunology |
650 | 0 | 4 |
_aSkin Neoplasms _ximmunology |
650 | 0 | 4 |
_aT-Lymphocyte Subsets _ximmunology |
700 | 1 | _aMcGurran, Sean M | |
700 | 1 | _aDow, Steven W | |
700 | 1 | _aSlansky, Jill E | |
700 | 1 | _aKedl, Ross M | |
773 | 0 |
_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 177 _gno. 1 _gp. 155-61 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.4049/jimmunol.177.1.155 _zAvailable from publisher's website |
999 |
_c16379738 _d16379738 |